The World Health Organization (WHO) yesterday recommended that the blood plasma of patients recovering from COVID-19 not be used to treat patients with the new disease. coronavirus, explaining that current data show that practice neither increases the chances of survival nor reduces the need for intubation.
The hypothesis of using blood plasma is that the antibodies it contains can neutralize SARS-CoV-2, stopping it from reproducing and reducing tissue damage.
But several studies on the use of blood plasma by recovering patients showed no substantial benefit in the treatment of people with severe COVID-19. A clinical trial in the United States was suspended in March after it was found that plasma did not even help treat patients with mild to moderate symptoms of the disease.
Strong texture
This method is expensive and time consuming, he added WHERE in a press release issued yesterday, APE-MPE reports, citing Reuters.
An international panel of experts has come up with a strong recommendation against the use of blood plasma by patients, the agency explained. The recommendation applies to all cases, with the exception of randomized, controlled trials.
The recommendation, published in the British Medical Journal (BMJ) review, is based on data from 16 trials in 16,236 patients with mild, severe and very severe COVID-19.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
